journal
Journals Pulmonary Pharmacology & Thera...

Pulmonary Pharmacology & Therapeutics

https://read.qxmd.com/read/37935327/ire1%C3%AE-xbp-1-promotes-%C3%AE-catenin-signaling-activation-of-airway-epithelium-in-lipopolysaccharide-induced-acute-lung-injury
#21
JOURNAL ARTICLE
Hailing Zhang, Jiehong Li, Xilong Wang, Kai Wang, JianPeng Xie, Guanjin Chen, Yijian Li, Kai Zhong, Jiahui Li, Xin Chen
BACKGROUND: Acute lung injury (ALI), along with the more severe condition--acute respiratory distress syndrome (ARDS), is a major cause of respiratory failure in critically ill patients with high morbidity and mortality. Inositol-requiring protein 1α (IRE1α)/X box protein-1 (XBP1) pathway was proved to regulate lipopolysaccharide (LPS)-induced lung injury and inflammation. Yet, its role on epithelial β-catenin in LPS-induced ALI remains to be elucidated. METHODS: LPS-induced models were generated in mice (5 mg/kg) and Beas-2B cells (200 μg/mL)...
November 5, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37923165/evaluation-of-body-weight-based-dosing-alternative-dosing-regimens-and-treatment-interruptions-for-%C3%AE-1-proteinase-inhibitors-and-implications-on-biochemical-efficacy-in-patients-with-%C3%AE-1-antitrypsin-deficiency
#22
JOURNAL ARTICLE
Zhaoyang Li, Mitali Gaurav, Leman Yel
INTRODUCTION: The recommended standard dose for α1 -proteinase inhibitor (A1PI) augmentation therapy is 60mg/kg once-weekly (QW) intravenous (IV) infusions that aim to maintain systemic A1PI levels >11μM, the biochemical efficacy threshold, in patients with α1 -antitrypsin deficiency (AATD). However, this standard dose may not be optimal for all patients. Body weight-based dosing, alternative dosing regimens, and treatment interruption periods were evaluated using population pharmacokinetic (PopPK) modeling and simulations...
November 1, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37879430/the-sirt3-activator-ganoderic-acid-d-regulates-airway-mucin-muc5ac-expression-via-the-nrf2-gpx4-pathway
#23
JOURNAL ARTICLE
Jiancheng Wang, Jiayao Li, Yingying He, Xiaochun Huang, Jianguo Feng, Li Liu, Yulin Liu, Xian Jiang, Jing Jia
PURPOSE: The expression of MUC5AC, a highly prevalent airway mucin, is regulated by stimulatory factors such as oxidative stress. Ganoderic acid D (GAD) activates mitochondrial deacetylase SIRT3. SIRT3 regulates mitochondrial function through deacetylation of mitochondrial proteins, thereby playing a significant role in alleviating oxidative stress-related diseases. Therefore, this study aimed to investigate the mechanisms and rationale underlying the regulation of MUC5AC expression by GAD...
October 23, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37741357/nontuberculous-mycobacterial-ntm-infections-in-bronchiectasis-patients-a-retrospective-us-registry-cohort-study
#24
JOURNAL ARTICLE
Myriam Drysdale, Radmila Choate, Amanda E Brunton, Simon Tiberi, Iain A Gillespie, Noah Lininger, Susan B Shrimpton, Mark Metersky, Nicole C Lapinel, Pamela J McShane, Christopher J Richards, Colin Swenson, Hema Sharma, David Mannino, Kevin L Winthrop
RATIONALE: Longitudinal epidemiological and clinical data are needed to improve the management of patients with bronchiectasis developing nontuberculous mycobacterial (NTM) pulmonary disease. OBJECTIVES: To describe the epidemiology, patient management, and treatment outcomes of NTM infections in patients with bronchiectasis enrolled in the United States Bronchiectasis and NTM Research Registry (US BRR). METHODS: This was a retrospective cohort study of patients with bronchiectasis and NTM infections enrolled with follow-up in the US BRR in 2008-2019...
September 21, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37726074/demethyleneberberine-alleviates-pseudomonas-aeruginosa-induced-acute-pneumonia-by-inhibiting-the-aim2-inflammasome-and-oxidative-stress
#25
JOURNAL ARTICLE
Yanhong Han, Chuang Ge, Junmei Ye, Ruiyan Li, Yubin Zhang
BACKGROUND: Acute pneumonia induced by Pseudomonas aeruginosa is characterized by massive infiltration of inflammatory cell and the production of reactive oxygen species (ROS), which lead to severe and transient pulmonary inflammation and acute lung injury. However, P.aeruginosa infection is resistant to multiple antibiotics and causes high mortality in clinic, the search for alternative prophylactic and therapeutic strategies is imperative. PURPOSE: This study was aimed to investigate the anti-inflammatory and antioxidant effects of DMB, a novel derivative of berberine, and explore the role of AIM2 inflammasome in P...
September 17, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37678663/safety-and-efficacy-of-p2x3-receptor-antagonist-for-the-treatment-of-refractory-or-unexplained-chronic-cough-a-systematic-review-and-meta-analysis-of-11-randomized-controlled-trials
#26
REVIEW
Alaa Ramadan, Mohamed El-Samahy, Amr Elrosasy, Mohammed Al-Tawil, Ahmed Abdelaziz, Mostafa A Soliman, Mohamed Abouzid
BACKGROUND AND OBJECTIVES: Chronic refractory cough is a challenging condition that requires a thorough evaluation and management approach. P2X3 receptors that are ATP-dependent play an important part in nerve fiber sensitization and pathological pain pathways. We conducted this systematic review and meta-analysis to determine the long-term safety and efficacy of P2X3 receptor antagonist drugs in chronic cough. METHODS: We systematically searched PubMed, Scopus, Web of Science, and Embase to identify all relevant published studies through January 15, 2023 that assessed P2X3 antagonists in chronic cough...
September 5, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37666296/m-6-a-modified-mir-143-3p-inhibits-epithelial-mesenchymal-transition-in-bronchial-epithelial-cells-and-extracellular-matrix-production-in-lung-fibroblasts-by-targeting-smad3
#27
JOURNAL ARTICLE
Jing Wang, Qiang Jian, Kun Yan, Jiao Yang, Liping Yan, Wei Cheng
BACKGROUND: Airway epithelial cells epithelial mesenchymal transition (EMT) and lung fibroblasts extracellular matrix (ECM) production are the key steps in airway remodeling. Our previous study demonstrated that miR-143-3p has the ability to impede airway smooth muscle cell proliferation and ECM deposition. However, the function of miR-143-3p in airway epithelial cells and lung fibroblasts remains unclear. METHODS: Cell viability was determined using MTT method, while cell migration was evaluated through scratch assay...
September 2, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37657752/knockdown-of-hdac10-inhibits-pole2-mediated-dna-damage-repair-in-nsclc-cells-by-increasing-sp1-acetylation-levels
#28
JOURNAL ARTICLE
Hua Guo, Hui Ren, Kun Han, Jianying Li, Yu Dong, Xuan Zhao, Chunqi Li
HDAC10 has been reported to be associated with poor prognosis in patients with non-small cell lung cancer (NSCLC), however, the regulatory role and mechanisms of HDAC10 in NSCLC have not been investigated. In this study, we found that HDAC10 was increased in NSCLC patients and cell lines. And high expression of HDAC10 is linked to poor survival in NSCLC patients. The results showed that knockdown of HDAC10 triggered DNA damage, S-phase arrest, and proliferation inhibition in A549 and H1299 cells. In addition, knockdown of HDAC10 promoted cell ferroptosis by enhancing ROS, MDA and Fe2+ levels...
August 30, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37648017/dihydroquercetin-dhq-ameliorates-lps-induced-acute-lung-injury-by-regulating-macrophage-m2-polarization-through-irf4-mir-132-3p-fbxw7-axis
#29
JOURNAL ARTICLE
Chen Li, Jianhua Liu, Changhong Zhang, Liang Cao, Fang Zou, Zhihua Zhang
BACKGROUND: Acute lung injury (ALI) is a common complication of sepsis. Dihydroquercetin (DHQ) has been found to attenuate lipopolysaccharide (LPS)-induced inflammation. However, the effect of DHQ on LPS-challenged ALI remains unclear. METHODS: Pulmonary HE and TUNEL staining and lung wet/dry ratio were detected in LPS-treated Balb/c mice. IL-1β, IL-6 and TNF-α levels were determined utilizing ELISA assay. RAW264.7 cell apoptosis and macrophage markers (CD86, CD206) were tested using flow cytometry...
August 28, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37574040/real-world-outcomes-of-cftr-modulator-therapy-in-australian-adults-and-children
#30
JOURNAL ARTICLE
Stephanie Kuek, Angela McCullagh, Eldho Paul, David Armstrong
BACKGROUND: Recent advances in CFTR modulator therapy have the potential to change the face of cystic fibrosis (CF). This retrospective observational study describes real world experience of the four available CFTR modulators in adults and children with CF in a single centre in Melbourne, Australia. METHOD: Data was collected for all patients treated with CFTR modulators at MonashCF between May 2012 and September 2020. Primary outcomes included lung function, admission days and BMI/BMI centile over time...
August 11, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37562641/the-effect-of-bradykinin-1-receptor-antagonist-bi-1026706-on-pulmonary-inflammation-after-segmental-lipopolysaccharide-challenge-in-healthy-smokers
#31
JOURNAL ARTICLE
Christina Gress, Jens Vogel-Claussen, Philipp Badorrek, Meike Müller, Kathrin Hohl, Marilisa Konietzke, Tobias Litzenburger, Wolfgang Seibold, Abhya Gupta, Jens M Hohlfeld
BACKGROUND: Bradykinin 1 receptor (B1R) signalling pathways may be involved in the inflammatory pathophysiology of chronic obstructive pulmonary disease (COPD). B1R signalling is induced by inflammatory stimuli or tissue injury and leads to activation and increased migration of pro-inflammatory cells. Lipopolysaccharide (LPS) lung challenge in man is an experimental method of exploring inflammation in the lung whereby interference in these pathways can help to assess pharmacologic interventions in COPD...
August 8, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37562640/effects-of-elexacaftor-tezacaftor-ivacaftor-on-daily-treatment-burden-and-airflow-obstruction-in-adults-with-cystic-fibrosis
#32
JOURNAL ARTICLE
Angelica Tiotiu, Iulia Ioan, Yves Billon
BACKGROUND: The drug combination elexacaftor-tezacaftor-ivacaftor (ETI) proved highly effective in the improvement of the respiratory symptoms, the percentage of predicted forced expiratory volume in 1 s (FEV1), and to reduce rates of pulmonary exacerbations in people with cystic fibrosis (CF) with at least one F508del mutation. The objectives of the study were to evaluate the impact of ETI on the daily treatment burden due to patient decision and the evolution of lung function parameters at 6 months of treatment in real life...
August 8, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37201652/chronic-obstructive-pulmonary-disease-and-emerging-er-stress-related-therapeutic-targets
#33
REVIEW
Jia Wen Yeap, Irfhan Ali Hyder Ali, Baharudin Ibrahim, Mei Lan Tan
COPD pathogenesis is frequently associated with endoplasmic reticulum stress (ER stress) progression. Targeting the major unfolded protein response (UPR) branches in the ER stress pathway may provide pharmacotherapeutic selection strategies for treating COPD and enable relief from its symptoms. In this study, we aimed to systematically review the potential role of the ER stress inhibitors of major UPR branches (IRE1, PERK, and ATF6) in COPD-related studies and determine the current stage of knowledge in this field...
August 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37499855/sirt3-alleviates-sepsis-induced-acute-lung-injury-by-inhibiting-pyroptosis-via-regulating-the-deacetylation-of-foxo3a
#34
JOURNAL ARTICLE
Zheqian Wu, Yong Wang, Shijie Lu, Lili Yin, Lihua Dai
OBJECTIVE: This study mainly analyzes the mechanism of SIRT3 alleviating sepsis-induced acute lung injury (ALI) by regulating the deacetylation of FoxO3a and inhibiting pyroptosis. METHODS: SIRT3-overexpressing and silenced BEAS-2B cells were used to evaluate the effect of SIRT3 on apoptosis in LPS-treated lung epithelial cells. FoxO3a-silenced BEAS-2B cells were also used to verify the mechanism by which SIRT3 inhibited oxidative stress and pyroptosis in vitro in ALI...
July 25, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37454870/impact-of-statin-treatment-and-exposure-on-the-risk-of-chronic-allograft-dysfunction-in-chinese-lung-transplant-recipients
#35
JOURNAL ARTICLE
Dan Zhang, Xiaoxing Wang, Wenwen Du, Wei Qin, Wenqian Chen, Xianbo Zuo, Pengmei Li
PURPOSE: Chronic lung allograft dysfunction (CLAD) was a common complication following lung transplantation that contributed to long-term morbidity and mortality. Statin therapy had been suggested to attenuate recipient inflammation and immune response, potentially reducing the risk and severity of CLAD. This study aimed to evaluate the impact of statin use and in vivo exposure on the incidence of CLAD in lung transplant recipients (LTRs), as well as their effects on immune cells and inflammatory factors...
July 16, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37451609/safety-and-efficacy-of-transitioning-from-selexipag-to-oral-treprostinil-in-pulmonary-arterial-hypertension-findings-from-the-adapt-registry
#36
JOURNAL ARTICLE
D Lachant, R Minkin, J Swisher, M Mogri, R Zolty, S Hwang, S Seaman, M Broderick, S Sahay
PURPOSE: Oral treprostinil and selexipag are drugs targeting the prostacyclin pathway and are approved for treatment of pulmonary arterial hypertension (PAH). In the setting of unsatisfactory clinical response or side effects while on selexipag, there is little data on clinical benefit, safety, or strategies on transitioning to oral treprostinil. Using prospective data from the ADAPT registry, we aimed to evaluate clinical outcomes, safety, and transition strategies in ten patients with PAH transitioning from selexipag to oral treprostinil...
July 12, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37414133/assessing-the-relationship-between-cardiovascular-and-small-airway-disease-and-acute-events-in-copd-the-arcadia-study-protocol
#37
JOURNAL ARTICLE
Paola Rogliani, Dejan Radovanovic, Josuel Ora, Nadia Starc, Stefano Verri, Elena Pistocchini, Luigino Calzetta
The initial alterations of chronic obstructive pulmonary disease (COPD) involve the small airways. Small airway disease (SAD) is related to lung hyperinflation and air trapping. Several lung function tests may detect the presence of SAD, namely forced mid-expiratory flows, residual volume (RV), RV/total lung capacity (TLC) ratio, functional residual capacity, airway resistances obtained with body-plethysmography and oscillometry, and the single-breath nitrogen washout test. Additionally, high-resolution computed tomography can detect SAD...
July 4, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37414132/safety-and-usefulness-of-nebulized-liposomal-amphotericin-b-systematic-scoping-review
#38
JOURNAL ARTICLE
Hideharu Hagiya, Yoshito Nishimura, Fumio Otsuka
PURPOSE: Invasive fungal infections potentially result in fatal outcomes in immunocompromised hosts. Compared to intravenous administration, a nebulization therapy can achieve a high concentration of drug delivered in the respiratory tract, without a systematic absorption. We herein summarized the study findings on the safety and clinical utility of nebulized liposomal amphotericin B therapy. METHODS: According to the PRISMA Extension for Scoping Reviews, we performed a search on MEDLINE and EMBASE for articles with relevant keywords, including "inhaled liposomal amphotericin B″, "nebulized liposomal amphotericin B″, or "aerosolized liposomal amphotericin B″, from the inception of these databases to August 31, 2022...
July 4, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37364767/amygdalin-epimers-exert-discrepant-anti-pulmonary-fibrosis-activity-via-inhibiting-tgf-%C3%AE-1-smad2-3-pathway
#39
JOURNAL ARTICLE
Haoyan Jiao, Shuyu Li, Qingfa Tang
Idiopathic pulmonary fibrosis (IPF) represents a chronic and progressive tissue repair response that leads to irreversible scarring and lung remodeling. The decoction of bitter almond usually contains amygdalin epimers in traditional clinical application for lung disease. To reveal the differences of cytotoxicity and antifibrotic effect between amygdalin epimers, and potential mechanism is also explored. The cytotoxicity of amygdalin epimers were evaluated with MRC-5 cells in vitro. Their antifibrotic activities were evaluated in bleomycin-induced C57BL/6 mice and TGF-β1-induced MRC-5 cells...
June 25, 2023: Pulmonary Pharmacology & Therapeutics
https://read.qxmd.com/read/37355202/preventive-effect-of-lcz696-on-hypoxic-pulmonary-hypertension-in-rats-via-regulating-the-pi3k-akt-signaling-pathway
#40
JOURNAL ARTICLE
Jie Wang, Yan-Rong Ma, Ya-E Chang, De-Long Duo, Kun-Kun Duan, Ni Zhao, Wen-Li Cui, Zhi-Lan Huan, Ya-Feng Wang
Hypoxic pulmonary hypertension (HPH) is a devastating disease worldwide; however, effective therapeutic drugs are lacking. This study investigated the effects and underlying mechanisms of LCZ696 treatment on hypoxia-induced pulmonary hypertension. Male Sprague-Dawley (SD) rats were kept in a hypobaric chamber with an oxygen concentration of 5% for 4 weeks. Rats were treated with either LCZ696 (18 mg/kg, 36 mg/kg, and 72 mg/kg) or sildenafil. The mean pulmonary artery pressure (mPAP), right ventricle hypertrophy index (RVHI), and lung system index were measured...
June 22, 2023: Pulmonary Pharmacology & Therapeutics
journal
journal
32865
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.